Corey C. Emerson

Corey C. Emerson

Auto-generated profile, based on publicly available information

Corey C. Emerson

Department of Pharmacology and Cleveland Center for Membrane and Structural Biology, Case Western Reserve University, Cleveland, OH 44106, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
ALAl de Leon
Al de Leon
RPReshani Perera
Reshani Perera
CHChristopher Hernandez
Christopher Hernandez
MCMichaela Cooley
Michaela Cooley
OJOlive Jung
Olive Jung
AEAgata A. Exner
Agata A. Exner
Advancement of ultrasound molecular imaging applications requires not only a reduction in size of the ultrasound contrast agents (UCAs) but also a significant improvement in the in vivo stability of the shell-stabilized gas bubble. The transition from first generation to second generation UCAs was marked by an advancement in stability as air was replaced by a hydrophobic gas, such as perfluoropropane and sulfur hexafluoride. Further improvement can be realized by focusing on how well the UCAs shell can retain the encapsulated gas under extreme mechanical deformations. Here we report the next generation of UCAs for which we engineered the shell structure to impart much better stability under repeated prolonged oscillation due to ultrasound, and large changes in shear and turbulence as it circulates within the body. By adapting an architecture with two layers of contrasting elastic properties similar to bacterial cell envelopes, our ultrastable nanobubbles (NBs) withstand continuous in vitro exposure to ultrasound with minimal signal decay and have a significant delay on the onset of in vivo signal decay in kidney, liver, and tumor. Development of ultrastable NBs can potentially expand the role of ultrasound in molecular imaging, theranostics, and drug delivery.

25 November 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SASvetlana Atasheva
Svetlana Atasheva
CECorey C. Emerson
Corey C. Emerson
JYJia Yao
Jia Yao
CYCedrick Young
Cedrick Young
PSPhoebe L. Stewart
Phoebe L. Stewart
DSDmitry M. Shayakhmetov
Dmitry M. Shayakhmetov
Safe and effective “designer” adenoviruses target tumors after systemic administration.